Previous Close | 8.13 |
Open | 8.10 |
Bid | 8.00 x 100 |
Ask | 8.06 x 200 |
Day's Range | 8.02 - 8.29 |
52 Week Range | 7.72 - 27.48 |
Volume | |
Avg. Volume | 1,050,638 |
Market Cap | 1.092B |
Beta (5Y Monthly) | 0.41 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Vir Biotechnology (VIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Vir Biotechnology Inc (NASDAQ:VIR), a company focused on the research and development of treatments for serious infectious diseases, has reported an insider sell according to a recent SEC filing.
Q4 2023 Vir Biotechnology Inc Earnings Call